Display Settings:

Format

Send to:

Choose Destination
    JSLS. 2003 Jul-Sep;7(3):211-8.

    Symptoms and antireflux medication use following laparoscopic Nissen fundoplication: outcome at 1 and 4 years.

    Source

    Department of Surgery, University of South Florida, College of Medicine, Tampa, Florida, USA.

    Erratum in

    • JSLS. 2003 Oct-Dec;7(4):388.

    Abstract

    BACKGROUND:

    We have reported 1-year outcomes and antacid medication use in 100 patients undergoing laparoscropic Nissen fundoplication. As a follow-up study, we queried these same patients to determine whether their outcomes endured 4 years after fundoplication.

    METHODS:

    One hundred patients undergoing laparoscopic Nissen fundoplication between 1992 and 1997 were asked, at 1 to 2 years and 4 to 6 years postoperatively, to grade their symptoms on a scale of 1 (mild) to 10 (severe). Patients were also queried as to the number/cost of antacid medications used before and after fundoplication.

    RESULTS:

    Significant improvements were noted in symptoms of heartburn, postprandial emesis, gas/bloating, and dysphagia after fundoplication. Significant decreases in antacid medication use (97% vs 19%) and monthly costs (dollar 168 +/- dollar 91 vs dollar 30 +/- 54) were seen following fundoplication. The number of patients on antacid medications and the monthly costs of these medications (37% and dollar 53 +/- dollar 87, respectively) increased significantly from early to late follow-up, but were still significantly lower than those before surgery. Overall, 87% and 900% of patients were pleased with their outcome at early and late follow-up, respectively, and 93% and 92% of patients stated they would consider undergoing fundoplication again if necessary (P = NS).

    CONCLUSION:

    Laparoscopic Nissen fundoplication results in a significant reduction in the symptoms of reflux and the use of antacid medications with a high degree of patient satisfaction. Although some patients return to antacid medications at late follow-up, they continue to have few symptoms and are pleased with their outcomes.

    PMID:
    14558708
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3113200
    Free PMC Article

      Supplemental Content

      Icon for Ingenta plc Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk